Valens Establishes Operations in the Greater Toronto Area with the Acquisition of a Leading Beverage CompanyOn November 11, 2019
Valens and BRNT Enter Into Major White Label Deal With a Gross Revenue Potential to Valens of More Than $50 MillionOn October 30, 2019October 30, 2019
Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019On October 15, 2019
Valens to Hold Conference Call to Discuss Financial Results for the Third Quarter of Fiscal 2019On October 9, 2019October 9, 2019
Valens Announces Results of Annual General and Special Meeting of ShareholdersOn September 24, 2019September 24, 2019
Valens Receives Amended License from Health Canada Permitting Sales Directly to Provinces and Territories & Provides Operational UpdateOn September 23, 2019
Valens Becomes First Third Party Processor to Enter Strategic Agreement with Shoppers Drug Mart to Supply Cannabis Oil ProductsOn September 16, 2019September 16, 2019
Valens Announces Five Year White Label Cannabis Infused Beverage Contract With Iconic Brewing Company’s Cannabis DivisionOn September 12, 2019
Valens Announces Guidance For Record Q3 2019 Revenue and Participation in Live Investor Webcast on September 12thOn September 10, 2019September 10, 2019
Extract 
Test 
